Market research
EKSO Ekso Bionics Holdings Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 9.5
- Dividend yield
- Not available
- Beta
- 0.78
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US2826444000
- Market cap
- 42M
- P/E ratio
- Not available
- Analyst target
- 9.5
- Dividend yield
- Not available
- Beta
- 0.78
About
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the EKSO discussion.
5 years, 4 months ago
Ekso Bionics Holdings, Inc is currently in a long term downtrend where the price is trading 17.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Ekso Bionics Holdings, Inc's total revenue sank by 39.4% to $2M since the same quarter in the previous year.
Its net income has dropped by 46.1% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 11.9% to $-2M since the same quarter in the previous year.
Based on the above factors, Ekso Bionics Holdings, Inc gets an overall score of 1/5.